These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 27060578)

  • 1. False Prolongation of Prothrombin Time in the Presence of a High Blood Concentration of Daptomycin.
    Yamada T; Kato R; Oda K; Tanaka H; Suzuki K; Ijiri Y; Ikemoto T; Nishihara M; Hayashi T; Tanaka K; Tamai H; Ukimura A; Katsumata T
    Basic Clin Pharmacol Toxicol; 2016 Oct; 119(4):353-9. PubMed ID: 27060578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent effect of daptomycin on the artificial prolongation of prothrombin time in coagulation abnormalities: in vitro verification.
    Hashimoto H; Saito M; Kanda N; Yamamoto T; Mieno M; Hatakeyama S
    BMC Pharmacol Toxicol; 2017 Nov; 18(1):74. PubMed ID: 29179737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observational study to determine the optimal dose of daptomycin based on pharmacokinetic/pharmacodynamic analysis.
    Yamada T; Ooi Y; Oda K; Shibata Y; Kawanishi F; Suzuki K; Nishihara M; Nakano T; Yoshida M; Uchida T; Katsumata T; Ukimura A
    J Infect Chemother; 2020 Apr; 26(4):379-384. PubMed ID: 31836287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Chiral Target of Daptomycin Is the 2R,2'S Stereoisomer of Phosphatidylglycerol.
    Moreira R; Taylor SD
    Angew Chem Int Ed Engl; 2022 Jan; 61(4):e202114858. PubMed ID: 34843157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent artificial prolongation of prothrombin time by interaction between daptomycin and test reagents in patients receiving warfarin: a prospective in vivo clinical study.
    Saito M; Hatakeyama S; Hashimoto H; Suzuki T; Jubishi D; Kaneko M; Kume Y; Yamamoto T; Suzuki H; Yotsuyanagi H
    Ann Clin Microbiol Antimicrob; 2017 Apr; 16(1):27. PubMed ID: 28399872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of Daptomycin to Anionic Lipid Vesicles Is Reduced in the Presence of Lysyl-Phosphatidylglycerol.
    Khatib TO; Stevenson H; Yeaman MR; Bayer AS; Pokorny A
    Antimicrob Agents Chemother; 2016 Aug; 60(8):5051-3. PubMed ID: 27216066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of replacing the ester bond with an amide bond and of overall stereochemistry on the activity of daptomycin.
    Moreira R; Barnawi G; Beriashvili D; Palmer M; Taylor SD
    Bioorg Med Chem; 2019 Jan; 27(1):240-246. PubMed ID: 30538064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of telavancin on coagulation test results.
    Barriere SL; Goldberg MR; Janc JW; Higgins DL; Macy PA; Adcock DM
    Int J Clin Pract; 2011 Jul; 65(7):784-9. PubMed ID: 21564449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model.
    Firsov AA; Smirnova MV; Lubenko IY; Vostrov SN; Portnoy YA; Zinner SH
    J Antimicrob Chemother; 2006 Dec; 58(6):1185-92. PubMed ID: 17028094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of daptomycin with two recombinant thromboplastin reagents leads to falsely prolonged patient prothrombin time/International Normalized Ratio results.
    Webster PS; Oleson FB; Paterson DL; Arkin CF; Mangili A; Craven DE; Adcock DM; Lindfield KC; Knapp AG; Martone WJ
    Blood Coagul Fibrinolysis; 2008 Jan; 19(1):32-8. PubMed ID: 18180613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration-response relationships as a basis for choice of the optimal endpoints of the antimicrobial effect: daptomycin and vancomycin pharmacodynamics with staphylococci in an in vitro dynamic model.
    Smirnova MV; Lubenko IY; Portnoy YA; Zinner SH; Firsov AA
    Int J Antimicrob Agents; 2007 Feb; 29(2):165-9. PubMed ID: 17207607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency and Distribution of Single-Nucleotide Polymorphisms within mprF in Methicillin-Resistant Staphylococcus aureus Clinical Isolates and Their Role in Cross-Resistance to Daptomycin and Host Defense Antimicrobial Peptides.
    Bayer AS; Mishra NN; Chen L; Kreiswirth BN; Rubio A; Yang SJ
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4930-7. PubMed ID: 26055370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatidylglycerol and daptomycin synergistically inhibit tissue factor-induced coagulation in the prothrombin time test.
    van den Besselaar AM; Breukink E; Koorengevel MC
    J Thromb Haemost; 2010 Jun; 8(6):1429-30. PubMed ID: 20345716
    [No Abstract]   [Full Text] [Related]  

  • 14. Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation.
    Warkentin TE; Greinacher A; Craven S; Dewar L; Sheppard JA; Ofosu FA
    Thromb Haemost; 2005 Nov; 94(5):958-64. PubMed ID: 16363236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligomerization of daptomycin on membranes.
    Muraih JK; Pearson A; Silverman J; Palmer M
    Biochim Biophys Acta; 2011 Apr; 1808(4):1154-60. PubMed ID: 21223947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of melagatran on prothrombin time assays depends on the sensitivity of the thromboplastin and the final dilution of the plasma sample.
    Mattsson C; Menschiek-Lundin A; Wåhlander K; Lindahl TL
    Thromb Haemost; 2001 Aug; 86(2):611-5. PubMed ID: 11522011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays.
    Lindahl TL; Baghaei F; Blixter IF; Gustafsson KM; Stigendal L; Sten-Linder M; Strandberg K; Hillarp A;
    Thromb Haemost; 2011 Feb; 105(2):371-8. PubMed ID: 21103660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simple and validated UHPLC method coupled to UV detection for determination of daptomycin in human plasma and urine.
    Naito T; Yamada T; Yagi T; Kawakami J
    Biomed Chromatogr; 2014 Mar; 28(3):317-9. PubMed ID: 24037956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daptomycin susceptibility of 833 strains of Gram-positive cocci from a university hospital in Japan (2009-2011).
    Yoshizumi A; Ishii Y; Iwata M; Murakami H; Yumoto S; Yasui K; Maehara C; Fukuzawa S; Enokizono K; Tateda K
    Diagn Microbiol Infect Dis; 2014 Oct; 80(2):151-3. PubMed ID: 25056827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of daptomycin oligomerization with perylene excimer fluorescence: stoichiometric binding of phosphatidylglycerol triggers oligomer formation.
    Muraih JK; Harris J; Taylor SD; Palmer M
    Biochim Biophys Acta; 2012 Mar; 1818(3):673-8. PubMed ID: 22079564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.